Literature DB >> 12029142

Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

Peter Vanlandschoot1, Freya Van Houtte1, Annelies Roobrouck1, Ali Farhoudi1, Geert Leroux-Roels1.   

Abstract

During hepatitis B virus (HBV) infection, high numbers of non-infectious HBV surface antigen (HBsAg) particles are present in circulation. It is shown here that recombinant HBsAg (rHBsAg) particles, which contain the S protein only, bind almost exclusively to monocytes. Attachment of rHBsAg to the THP-1 pre-monocytic cell line occurs upon 1,25-dihydroxyvitamin D3-induced differentiation. Binding to monocytes is enhanced by a heat-labile serum protein and is inhibited by Ca(2+)/Mg(2+), low pH and an HBsAg-specific monoclonal antibody. Furthermore, it is shown that rHBsAg suppresses lipopolysaccharide- and IL-2-induced production of cytokines. These results suggest the existence of a monocyte-specific receptor, the engagement of which by HBsAg suppresses the activity of these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029142     DOI: 10.1099/0022-1317-83-6-1281

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Association of promoter polymorphism of the CD14 C (-159) T endotoxin receptor gene with chronic hepatitis B.

Authors:  Amir Houshang Mohammad Alizadeh; Mitra Ranjbar; Mehrdad Hajilooi; Farahnaz Fallahian
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 2.  Old and new adjuvants for hepatitis B vaccines.

Authors:  Geert Leroux-Roels
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

3.  The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.

Authors:  Pengyuan Yang; Geoffrey J Markowitz; Xiao-Fan Wang
Journal:  Natl Sci Rev       Date:  2014-07-14       Impact factor: 17.275

4.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.

Authors:  Marjoleine L Op den Brouw; Rekha S Binda; Mark H van Roosmalen; Ulrike Protzer; Harry L A Janssen; Renate G van der Molen; Andrea M Woltman
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

5.  Study of human B7 homolog 1 expression in patients with hepatitis B virus infection.

Authors:  Wen-Jin Zhang; Hai-Yang Xie; Xin Duan; Yun-Le Wan; Chuan-Hui Peng; Shao-Hua Shi; Rong Su; Zhang-Hui Zheng; Le-Lin Pan; Lin Zhou; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

6.  Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function.

Authors:  Andrea M Woltman; Marjoleine L Op den Brouw; Paula J Biesta; Cui C Shi; Harry L A Janssen
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

7.  Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages.

Authors:  Moses T Bility; Liang Cheng; Zheng Zhang; Yan Luan; Feng Li; Liqun Chi; Liguo Zhang; Zhengkun Tu; Yanhang Gao; Yangxin Fu; Junqi Niu; Fusheng Wang; Lishan Su
Journal:  PLoS Pathog       Date:  2014-03-20       Impact factor: 6.823

8.  Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection.

Authors:  Yasuteru Kondo; Masashi Ninomiya; Eiji Kakazu; Osamu Kimura; Tooru Shimosegawa
Journal:  ISRN Gastroenterol       Date:  2013-01-16

9.  The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.

Authors:  John E Tavis; Xiaohong Cheng; Yuan Hu; Michael Totten; Feng Cao; Eleftherios Michailidis; Rajeev Aurora; Marvin J Meyers; E Jon Jacobsen; Michael A Parniak; Stefan G Sarafianos
Journal:  PLoS Pathog       Date:  2013-01-22       Impact factor: 6.823

10.  Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Authors:  Faseeha Noordeen; Catherine A Scougall; Arend Grosse; Qiao Qiao; Behzad B Ajilian; Georget Reaiche-Miller; John Finnie; Melanie Werner; Ruth Broering; Joerg F Schlaak; Andrew Vaillant; Allison R Jilbert
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.